Notice Number: NOT-DA-19-027
Key Dates
Release Date: March 1, 2019
Issued by
National Institute on Drug Abuse (NIDA)
Purpose
The Purpose of the Notice is to inform potential applicants that the National Institute on Drug Abuse (NIDA) will participate, effective immediately, in PA-19-188 "Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)".
The following sections have been updated in the FOA to reflect the participation of NIDA.
Part 1. Overview Information
Components of Participating Organizations
National Center for Complementary and Integrative Health (NCCIH)
National Cancer Institute (NCI)National Human Genome Research Institute (NHGRI)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Drug Abuse (NIDA)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of Mental Health (NIMH)
National Institute on Minority Health and Health Disparities (NIMHD)
National Institute of Nursing Research (NINR)
Special Note: Not all NIH Institutes and Centers participate in Parent Announcements. Applicants should carefully note which ICs participate in this announcement and view their respective areas of research interest and requirements at theTable of IC-Specific Information, Requirements and Staff Contactswebsite. ICs that do not participate in this announcement will not consider applications for funding. Consultation with NIH staff before submitting an application is strongly encouraged.
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.213; 93.398; 93.172; 93.837; 93.838; 93.839; 93.840; 93.233; 93.866; 93.273; 93.846; 93.865; 93.173; 93.121; 93.847; 93.113; 93.242; 93.307; 93.853; 93.879; 93.361;93.279
All other aspects of this FOA remain the same.
Inquiries
Please direct all inquiries to:
Michele Rankin, Ph.D.
National Institute on Drug Abuse (NIDA)
Phone: (301) 480-3832
Email: [email protected]